PURPOSE: To study the relationship between structure of poly(ethylene imine-co-ethylene glycol), PEI-PEG, copolymers and physicochemical properties as well as in vivo behavior of their complexes with NF-kappaB decoy. METHODS: A variety of copolymers of PEG grafted onto PEI as well as PEI grafted onto PEG were synthesized and their complexes with a double stranded 20mer oligonucleotide were examined regarding size, surface charge, biodistribution and pharmacokinetics. RESULTS: Polyplexes of copolymers were smaller compared to polyplexes formed by non-PEGylated PEI 25 kDa (58 - 334 nm vs. 437 nm for a nitrogen/phosphate ratio of 3.5 and 85 - 308 nm vs. 408 nm for N/P 6.0) and showed reduced zeta potential (-2.5 - 6.4 mV vs. 14.5 mV for N/P 6.0). IV injection into mice revealed liver (35-76% of injected dose), kidney (3 - 22%) and spleen (2 - 16%) to be the main target organs for all injected complexes. Complexes formed by copolymers with few PEG blocks of higher molecular weight (5 kDa and 20 kDa) grafted onto PEI 25 kDa did not show different blood levels from PEI 25 kDa. In contrast, a copolymer with more short PEG blocks (550 Da) grafted onto PEI showed elevated blood levels with an increase in AUC of 62 %. CONCLUSIONS: A sufficiently high density of PEG molecules is necessary to effectively prevent opsonization and thereby rapid clearance from blood stream.
PURPOSE: To study the relationship between structure of poly(ethylene imine-co-ethylene glycol), PEI-PEG, copolymers and physicochemical properties as well as in vivo behavior of their complexes with NF-kappaB decoy. METHODS: A variety of copolymers of PEG grafted onto PEI as well as PEI grafted onto PEG were synthesized and their complexes with a double stranded 20mer oligonucleotide were examined regarding size, surface charge, biodistribution and pharmacokinetics. RESULTS:Polyplexes of copolymers were smaller compared to polyplexes formed by non-PEGylated PEI 25 kDa (58 - 334 nm vs. 437 nm for a nitrogen/phosphate ratio of 3.5 and 85 - 308 nm vs. 408 nm for N/P 6.0) and showed reduced zeta potential (-2.5 - 6.4 mV vs. 14.5 mV for N/P 6.0). IV injection into mice revealed liver (35-76% of injected dose), kidney (3 - 22%) and spleen (2 - 16%) to be the main target organs for all injected complexes. Complexes formed by copolymers with few PEG blocks of higher molecular weight (5 kDa and 20 kDa) grafted onto PEI 25 kDa did not show different blood levels from PEI 25 kDa. In contrast, a copolymer with more short PEG blocks (550 Da) grafted onto PEI showed elevated blood levels with an increase in AUC of 62 %. CONCLUSIONS: A sufficiently high density of PEG molecules is necessary to effectively prevent opsonization and thereby rapid clearance from blood stream.
Authors: P Erbacher; T Bettinger; P Belguise-Valladier; S Zou; J L Coll; J P Behr; J S Remy Journal: J Gene Med Date: 1999 May-Jun Impact factor: 4.565
Authors: Alexander C Eldredge; Mark E Johnson; Yang Cao; Lin Zhang; Can Zhao; Zhengxia Liu; Qin Yang; Zhibin Guan Journal: Biomaterials Date: 2018-04-16 Impact factor: 12.479
Authors: Alexey V Ulasov; Yuri V Khramtsov; Georgiy A Trusov; Andrey A Rosenkranz; Eugene D Sverdlov; Alexander S Sobolev Journal: Mol Ther Date: 2010-11-02 Impact factor: 11.454
Authors: C A Fernandez; N J Baumhover; J T Duskey; S Khargharia; K Kizzire; M D Ericson; K G Rice Journal: Gene Ther Date: 2010-08-19 Impact factor: 5.250
Authors: Mikhail O Durymanov; Elena A Beletkaia; Alexey V Ulasov; Yuri V Khramtsov; Georgiy A Trusov; Nikita S Rodichenko; Tatiana A Slastnikova; Tatiana V Vinogradova; Natalia Y Uspenskaya; Eugene P Kopantsev; Andrey A Rosenkranz; Eugene D Sverdlov; Alexander S Sobolev Journal: J Control Release Date: 2012-09-01 Impact factor: 9.776
Authors: Anisha Shakya; Casey A Dougherty; Yi Xue; Hashim M Al-Hashimi; Mark M Banaszak Holl Journal: Biomacromolecules Date: 2015-12-11 Impact factor: 6.988
Authors: Olivia M Merkel; Meredith A Mintzer; Johannes Sitterberg; Udo Bakowsky; Eric E Simanek; Thomas Kissel Journal: Bioconjug Chem Date: 2009-09 Impact factor: 4.774